ZIELENKIEWICZ; Piotr

Patent Applications and Registrations

Patent applications and USPTO patent grants for ZIELENKIEWICZ; Piotr.The latest application filed is for "methods and compositions for modifying cystic fibrosis transmembrane conductance regulator activity".

Company Profile

4.3.8

ZIELENKIEWICZ; Piotr - WARSZAWA PL
Zielenkiewicz; Piotr - Warsaw PL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Compositions For Modifying Cystic Fibrosis Transmembrane Conductance Regulator Activity App 20190391160 - ODOLCZYK; Norbert ; et al.	2019-12-26
Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction Grant 10,463,639 - Odolczyk , et al. No	2019-11-05
Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction Grant 10,420,738 - Odolczyk , et al. Sept	2019-09-24
Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction Grant 10,398,665 - Odolczyk , et al. Sep	2019-09-03
Method of using a miR172 Molecule for Decreasing Inflammation App 20160272966 - Lukasik; Anna ; et al.	2016-09-22
Compounds As Modulators Of A Mutant Cftr Protein And Their Use For Treating Diseases Associated With Cftr Protein Malfunction App 20160113896 - Odolczyk; Norbert ; et al.	2016-04-28
Compounds As Modulators Of A Mutant Cftr Protein And Their Use For Treating Diseases Associated With Cftr Protein Malfunction App 20160101107 - Odolczyk; Norbert ; et al.	2016-04-14
Compounds As Modulators Of A Mutant Cftr Protein And Their Use For Treating Diseases Associated With Cftr Protein Malfunction App 20160095869 - Odolczyk; Norbert ; et al.	2016-04-07
Compounds As Modulators Of A Mutant Cftr Protein And Their Use For Treating Diseases Associated With Cftr Protein Malfunction App 20160000778 - ODOLCZYK; Norbert ; et al.	2016-01-07
Compounds As Modulators Of A Mutant Cftr Protein And Their Use For Treating Diseases Associated With Cftr Protein Malfunction App 20130303761 - Odolczyk; Norbert ; et al.	2013-11-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.